The 6th Annual Ophthalmic Drugs Conference (hosted by SAE Media Group/SMi Group) takes place on November 20–21, 2023, in London, UK. The 2023 event explores innovations in ocular therapeutics, novel gene therapies, and treatments for rare ophthalmic diseases.
The main highlights and topics to be discussed includes:
Gene Therapies & Rare Diseases: Breakthroughs in treating severe ocular genetic disorders.
Drug Delivery Advancements: Transitioning from traditional topical drops to extended-release approaches, sustained delivery systems, and sustained-activity mechanisms.
Regulatory Updates & Clinical Trials: Discussions on nonsteroidal anti-inflammatory agents (NSAIDs) and managing the side effects of ophthalmic drugs.
Emerging Pipeline Assets: New non-invasive delivery systems and the commercialization of therapies for retinal conditions and age-related macular degeneration (AMD).
The conference brings together industry experts, researchers, and pharmaceutical leaders to discuss the commercial and technical hurdles of developing ophthalmic drugs.